Observational study on vulvar cancer

The purpose of this study is to investigate the safety of replacing complete inguino femoral lymphadenectomy by adjuvant radiotherapy in early stage vulvar cancer patients with a sentinel node metastasis < or = 2 mm.


This research study is led by Dr. Tashanna Myers.

Contact: Laura Sorci, 413-794-3188

Participation details:

January 03, 2012
Cancer, Cancer-Gynecologic
  • D’Amour Center for Cancer Care, 3350 Main Street , Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Sampling Method: Non-Probability Sample

Inclusion Criteria:

  • Patients must have squamous cell carcinoma with a depth invasion > 1 mm
  • Patients must have T1 or T2 tumors (International Federation of Gynecology and Obstetrics[FIGO] staging), < 4 cm, not encroaching in urethra, vagina, or anus with clinically negative inguinofemoral lymph nodes
  • Localization and size of the tumor are such that peri-lesional injection of the tracers at three or four sites is possible
  • Preoperative imaging do not show enlarged (< 1.5 cm) suspicious nodes

Exclusion Criteria:

  • Inoperable tumors with diameter > 4 cm
  • Patients with multifocal tumors
  • Patients who are currently on an investigational drug for the treatment of vulvar cancer are excluded from participation in this trial